Description
Pancragen is a synthetic tetrapeptide bioregulator studied for its activity in pancreatic tissue. Research indicates that Pancragen may influence endocrine signaling pathways, including those related to glucose metabolism and melatonin regulation. Experimental studies have explored its potential relevance in models of metabolic dysregulation and age-related endocrine changes. Pancragen is of particular interest in investigations focused on pancreatic function and systemic metabolic balance.